Cargando…

Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models

Imaging of clinically relevant preclinical animal models is critical to the development of personalized therapeutic strategies for endometrial carcinoma. Although orthotopic patient-derived xenografts (PDXs) reflecting heterogeneous molecular subtypes are considered the most relevant preclinical mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonnes, Tina, Strand, Elin, Fasmer, Kristine E., Berg, Hege F., Espedal, Heidi, Sortland, Kristina, Stefansson, Ingunn, Bjørge, Line, Haldorsen, Ingfrid S., Krakstad, Camilla, McCormack, Emmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072497/ https://www.ncbi.nlm.nih.gov/pubmed/32041116 http://dx.doi.org/10.3390/cancers12020370

Ejemplares similares

Feasibility and utility of MRI and dynamic (18)F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer
por: Espedal, Heidi, et al.
Publicado: (2021)

Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy
por: Espedal, Heidi, et al.
Publicado: (2019)

Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
por: Berg, Hege F., et al.
Publicado: (2021)

Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
por: Berg, Hege F., et al.
Publicado: (2021)

Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma
por: Haldorsen, Ingfrid S., et al.
Publicado: (2015)

Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer
por: Engerud, Hilde, et al.
Publicado: (2019)

MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer
por: Dybvik, Julie Andrea, et al.
Publicado: (2022)

A radiogenomics application for prognostic profiling of endometrial cancer
por: Hoivik, Erling A., et al.
Publicado: (2021)

Blood Metabolites Associate with Prognosis in Endometrial Cancer
por: Strand, Elin, et al.
Publicado: (2019)

Whole‐Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer
por: Fasmer, Kristine E., et al.
Publicado: (2020)

An MRI-Based Radiomic Prognostic Index Predicts Poor Outcome and Specific Genetic Alterations in Endometrial Cancer
por: Jacob, Havjin, et al.
Publicado: (2021)

Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers
por: Berg, Anna, et al.
Publicado: (2017)

Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma
por: Berg, Hege F., et al.
Publicado: (2020)

Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer
por: Fasmer, Kristine E., et al.
Publicado: (2020)

Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer
por: Berg, Anna, et al.
Publicado: (2016)

Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure
por: Konings, Gonda FJ, et al.
Publicado: (2018)

Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease
por: Lien, Hilde E., et al.
Publicado: (2023)

Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas
por: Ytre-Hauge, Sigmund, et al.
Publicado: (2015)

The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer
por: Helland, Øystein, et al.
Publicado: (2016)

Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595]
por: Lien, Hilde E., et al.
Publicado: (2023)

Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients
por: Eritja, Núria, et al.
Publicado: (2017)

First In-Mouse Development and Application of a Surgically Relevant Xenograft Model of Ovarian Carcinoma
por: Helland, Øystein, et al.
Publicado: (2014)

Automated segmentation of endometrial cancer on MR images using deep learning
por: Hodneland, Erlend, et al.
Publicado: (2021)

HER2 expression patterns in paired primary and metastatic endometrial cancer lesions
por: Halle, Mari Kyllesø, et al.
Publicado: (2018)

Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022)

Preoperative pelvic MRI and 2-[(18)F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?
por: Fasmer, Kristine E., et al.
Publicado: (2022)

High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma
por: Bischof, Katharina, et al.
Publicado: (2018)

Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model
por: García de Jalón, Elvira, et al.
Publicado: (2021)

The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
por: Kleinmanns, Katrin, et al.
Publicado: (2020)

Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
por: van Weelden, Willem Jan, et al.
Publicado: (2019)

Patient-Derived Xenograft Models for Endometrial Cancer Research
por: Moiola, Cristian P., et al.
Publicado: (2018)

Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value
por: Berg, Hege F., et al.
Publicado: (2022)

What Is the Best Preoperative Imaging for Endometrial Cancer?
por: Haldorsen, Ingfrid S., et al.
Publicado: (2016)

CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
por: Kleinmanns, Katrin, et al.
Publicado: (2020)

MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer
por: Wagner‐Larsen, Kari S., et al.
Publicado: (2023)

Molecular and phenotypic characteristics influencing the degree of cytoreduction in high‐grade serous ovarian carcinomas
por: Torkildsen, Cecilie Fredvik, et al.
Publicado: (2023)

High visceral fat percentage is associated with poor outcome in endometrial cancer
por: Mauland, Karen Klepsland, et al.
Publicado: (2017)

CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
por: Kleinmanns, Katrin, et al.
Publicado: (2020)

Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer
por: Stefansson, Ingunn M., et al.
Publicado: (2015)

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival
por: Halle, Mari K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3efk70guhd1rci3j894sqpfejj